The case of a woman with spinal muscular atrophy (SMA) type 2 who developed an abnormal accumulation of molecules…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
Training with a wearable robotic device called HAL, for hybrid assistive limb, improved walking ability for people with spinal…
SMA Europe will host its 1st International Clinical Care Symposium on SMA and focus on the biological causes…
Treatment with Spinraza (nusinersen) and physical therapy that focused on posture improved motor skills in a young boy with…
Most adolescents and adults with spinal muscular atrophy (SMA) have normal sensory nerve function, even those with long-lasting disease,…
Poor sleep is associated with more severe depressive symptoms and respiratory issues in adults with spinal muscular atrophy (SMA),…
Newborn screening (NBS) programs for spinal muscular atrophy (SMA) were available in 33 countries as of the beginning of…
Limited social interaction and difficulties in accessing needed medications and physical therapy were consequences of the COVID-19 pandemic, parents and…
Nonadherence of spinal muscular atrophy (SMA) patients to their prescribed regimen of Evrysdi (risdiplam) — an oral solution…
Blood levels of creatinine, a byproduct of normal muscle function, may be a potential biomarker of disease severity and treatment…